WeVote
Log In

Bill

Bill

AB 1587

Prescription drug refills: prescriber notifications.

2025-2026 Regular Session Introduced by Tri Ta

Allows pharmacists to furnish up to a 30-day supply of life-saving drugs without a new prescription in life-threatening cases, with liability protection and prescriber notification

Read second time. Ordered to Consent Calendar.
#prescriptiondrugrefills #prescribernotifications
0
WeVote Research Nonpartisan
Bill Summary · AB 1587

Summary of AB 1587 (2025-2026) — Prescription Drug Refills: Prescriber Notifications

Jurisdiction: California

Bill number: AB 1587
Sponsor: Assembly Member Ta (co-sponsor: Tri Ta)

Purpose and intent
- To modify California law governing pharmacist authority and notifications related to prescription refills.
- Specifically addresses refills of dangerous drugs and establishes a mechanism for furnishing life-saving medications under certain conditions, while clarifying liability and notification requirements.

Main provisions and changes proposed
- Life-threatening condition refills (Section 4052):
- Allows a pharmacist to furnish up to a 30-day supply of a prescription drug for a life-threatening condition if:
- The patient has previously received that drug from the same pharmacy or a pharmacy under common control.
- The patient cannot obtain a new prescription before the existing supply is exhausted.
- The pharmacist or pharmacy would not incur liability for furnishing the drug under this provision.
- The term “life-threatening” aligns with the Health and Safety Code’s definition in Section 1367.21.
- Notification: The bill requires notifying the patient’s prescriber only if a prescriber is identified, consistent with existing notification practices for refills dispensed without explicit prescriber authorization.

  • Refill without prescriber authorization (Section 4064):

    • Retains the existing framework that allows refills without prescriber authorization when the prescriber is unavailable and the refill is necessary to prevent interruption of ongoing care.
    • Requires the pharmacist to inform the patient that a refill was dispensed under this provision.
    • Requires the pharmacist to inform the prescriber within a reasonable period of time when such refills are dispensed, provided a prescriber can be identified.
    • Provides immunity from liability for the refilling pharmacist in these circumstances.

  • General scope of pharmacist authority (Section 4052):

    • Consolidates and restates a wide range of pharmacist authorities (office-use compounding, device furnishing, immunizations, smoking-cessation, contraception-related services, emergency contraception, travel medications, etc.), consistent with existing law.
    • Adds a requirement to notify the patient’s primary care provider of drugs or devices furnished or to provide a patient-record entry, if the patient has a PCP. If no PCP, the patient should receive a written record and be advised to consult a physician of their choice.
    • Clarifies that there is no obligation to perform services if:
    • The pharmacist lacks adequate education/experience or access to information.
    • Providing the service would place a patient at risk.
    • Pharmacy staffing is insufficient to support comprehensive patient care.
    • Maintains confidentiality and licensing considerations, and clarifies payment obligations for services.

Who would be affected
- Pharmacists and pharmacies:
- Eligible to furnish up to a 30-day supply of life-saving drugs in specific circumstances without a new prescription, with liability protections.
- Required to notify prescribers (when identified) and to document or communicate with patients and, where applicable, with PCPs.
- Patients with life-threatening conditions:
- Potential access to a 30-day supply of certain drugs when a prescription cannot be obtained promptly, intended to prevent gaps in critical treatment.
- Health care providers (prescribers and PCPs):
- Might receive prescriber notifications when life-saving refills are dispensed and will have access to patient records or notices as allowed by their information-sharing arrangements.

Procedural and timeline aspects
- Legislative process status (as of the provided text):
- Read second time and ordered to Consent Calendar (April 16, 2026).
- Previously reported from committees with “Do pass” recommendations and re-references.
- Action history indicates ongoing committee and floor consideration during the 2025–2026 regular session.
- Implementation timeline:
- If enacted, the changes would take effect upon enactment and subsequent regulatory updates. Specific transition dates are not listed in the text provided.

Key details and numbers
- 30-day supply limit for life-threatening conditions.
- Immunization and other pharmacist authorities remain within existing policy structures, with clarifications about notification and documentation.
- Liability protections for pharmacists furnishing life-saving drugs under the new 30-day provision.

Overall assessment
- AB 1587 seeks to balance patient access to essential medications in life-threatening situations with continued physician oversight by requiring prescriber notification when possible.
- It codifies a narrowly tailored expansion of pharmacist authority to furnish a short-term supply in emergencies, paired with protective liability provisions and documentation requirements.
- The bill also reinforces existing refill-without-prescriber-authorization rules and expands communication and record-sharing practices to include primary care providers where available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.